Unknown

Dataset Information

0

Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function.


ABSTRACT: Glycogen storage disease type 1b (GSD-1b) is an autosomal-recessive disease caused by mutation of glucose-6-phosphate transporter and characterized by altered glycogen/glucose homeostasis. A higher frequency of autoimmune diseases has been observed in GSD-1b patients, but the molecular determinants leading to this phenomenon remain unknown. To address this question, we investigated the effect of glucose-6-phosphate transporter mutation on immune cell homeostasis and CD4+ T cell functions. In GSD-1b subjects, we found lymphopenia and a reduced capacity of T cells to engage glycolysis upon TCR stimulation. These phenomena associated with reduced expression of the FOXP3 transcription factor, lower suppressive function in peripheral CD4+CD25+FOXP3+ regulatory T cells, and an impaired capacity of CD4+CD25- conventional T cells to induce expression of FOXP3 after suboptimal TCR stimulation. These data unveil the metabolic determinant leading to an increased autoimmunity risk in GSD-1b patients.

SUBMITTER: Melis D 

PROVIDER: S-EPMC5421305 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function.

Melis Daniela D   Carbone Fortunata F   Minopoli Giorgia G   La Rocca Claudia C   Perna Francesco F   De Rosa Veronica V   Galgani Mario M   Andria Generoso G   Parenti Giancarlo G   Matarese Giuseppe G  

Journal of immunology (Baltimore, Md. : 1950) 20170407 10


Glycogen storage disease type 1b (GSD-1b) is an autosomal-recessive disease caused by mutation of glucose-6-phosphate transporter and characterized by altered glycogen/glucose homeostasis. A higher frequency of autoimmune diseases has been observed in GSD-1b patients, but the molecular determinants leading to this phenomenon remain unknown. To address this question, we investigated the effect of glucose-6-phosphate transporter mutation on immune cell homeostasis and CD4<sup>+</sup> T cell functi  ...[more]

Similar Datasets

| S-EPMC3974180 | biostudies-literature
| S-EPMC5962277 | biostudies-literature
| S-EPMC3119727 | biostudies-literature
| S-EPMC4761472 | biostudies-literature
| S-EPMC2766617 | biostudies-literature
| S-EPMC10718061 | biostudies-literature
| S-EPMC9727171 | biostudies-literature
| S-EPMC1376902 | biostudies-other
| S-EPMC5499662 | biostudies-literature
| S-EPMC3578426 | biostudies-literature